Fonar PE Ratio 2006-2019 | FONR

Current and historical p/e ratio for Fonar (FONR) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Fonar PE ratio as of January 17, 2020 is 9.59.
Fonar PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-01-17 20.75 9.43
2019-09-30 20.67 $2.20 9.40
2019-06-30 21.51 $2.21 9.73
2019-03-31 20.47 $2.99 6.85
2018-12-31 20.24 $2.94 6.88
2018-09-30 24.90 $3.04 8.19
2018-06-30 26.55 $3.10 8.56
2018-03-31 29.80 $2.53 11.78
2017-12-31 24.35 $2.90 8.40
2017-09-30 30.50 $2.92 10.45
2017-06-30 27.75 $2.92 9.50
2017-03-31 17.55 $3.01 5.83
2016-12-31 19.15 $2.58 7.42
2016-09-30 20.54 $2.48 8.28
2016-06-30 20.36 $2.37 8.59
2016-03-31 15.38 $2.27 6.78
2015-12-31 17.26 $2.13 8.10
2015-09-30 13.41 $2.00 6.71
2015-06-30 10.58 $1.95 5.42
2015-03-31 13.04 $1.71 7.62
2014-12-31 10.40 $1.66 6.27
2014-09-30 11.01 $1.59 6.92
2014-06-30 12.20 $1.58 7.72
2014-03-31 17.58 $1.70 10.34
2013-12-31 21.21 $1.61 13.17
2013-09-30 5.77 $1.49 3.87
2013-06-30 6.56 $1.34 4.90
2013-03-31 6.92 $0.82 8.44
2012-12-31 4.33 $0.85 5.09
2012-09-30 3.75 $0.88 4.26
2012-06-30 4.10 $0.90 4.56
2012-03-31 2.68 $0.72 3.72
2011-12-31 1.70 $0.72 2.37
2011-09-30 1.96 $0.72 2.72
2011-06-30 1.96 $0.55 3.56
2011-03-31 1.68 $0.52 3.23
2010-12-31 1.30 $0.32 4.06
2010-09-30 1.39 $-0.18 0.00
2010-06-30 1.47 $-0.60 0.00
2010-03-31 1.91 $-0.62 0.00
2009-12-31 1.57 $-0.62 0.00
2009-09-30 2.14 $-0.36 0.00
2009-06-30 1.90 $-0.01 0.00
2009-03-31 0.84 0 0.00
2008-12-31 0.83 0 0.00
2008-09-30 1.18 0 0.00
2008-06-30 2.25 0 0.00
2008-03-31 3.81 0 0.00
2007-12-31 5.20 0 0.00
2007-09-30 6.71 0 0.00
2007-06-30 4.97 0 0.00
2007-03-31 6.50 0 0.00
2006-12-31 7.00 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.136B $0.087B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $159.317B 22.01
Abbott Laboratories (ABT) United States $156.119B 28.48
Stryker (SYK) United States $78.360B 26.35
Boston Scientific (BSX) United States $60.213B 28.42
Baxter (BAX) United States $45.945B 27.86
Essilor Luxottica (ESLOY) France $34.669B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.600B 19.20
Lonza Group Ag (LZAGY) Switzerland $28.331B 0.00
Terumo (TRUMY) Japan $27.798B 34.69
Coloplast (CLPBY) Denmark $27.302B 42.13
ResMed (RMD) United States $23.111B 42.63
Smith & Nephew SNATS (SNN) United Kingdom $21.536B 0.00
Sunny Optical Technology (SNPTF) China $19.930B 0.00
Insulet (PODD) United States $11.836B 563.12
Bio-Rad Laboratories (BIO) United States $11.366B 54.56
Canopy Growth (CGC) Canada $8.470B 0.00
Perrigo (PRGO) Ireland $8.100B 15.10
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.790B 22.90
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.880B 39.73
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.131B 32.53
ICU Medical (ICUI) United States $3.896B 25.40
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.868B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.680B 0.00
Neogen (NEOG) United States $3.677B 61.18
Quidel (QDEL) United States $3.119B 29.60
Agios Pharmaceuticals (AGIO) United States $3.035B 0.00
National Vision Holdings (EYE) United States $2.590B 58.45
Aurora Cannabis (ACB) Canada $2.342B 0.00
Cardiovascular Systems (CSII) United States $1.844B 0.00
AtriCure (ATRC) United States $1.453B 0.00
InMode (INMD) Israel $1.430B 0.00
TG Therapeutics (TGTX) United States $1.397B 0.00
Aphria (APHA) $1.311B 0.00
VAREX IMAGING (VREX) United States $1.218B 24.35
NanoString Technologies (NSTG) United States $1.102B 0.00
Phibro Animal Health (PAHC) United States $1.058B 19.82
PetIQ (PETQ) United States $0.884B 21.56
Eagle Pharmaceuticals (EGRX) United States $0.814B 31.18
Lantheus Holdings (LNTH) United States $0.740B 18.49
LeMaitre Vascular (LMAT) United States $0.740B 41.57
Omeros (OMER) United States $0.736B 0.00
Quanterix (QTRX) United States $0.693B 0.00
Cerus (CERS) United States $0.589B 0.00
MacroGenics (MGNX) United States $0.567B 0.00
Surmodics (SRDX) United States $0.561B 58.15
Organigram Holdings (OGI) Canada $0.531B 0.00
OraSure Technologies (OSUR) United States $0.515B 30.93
HEXO (HEXO) $0.484B 0.00
Meridian Bioscience (VIVO) United States $0.428B 14.71
Utah Medical Products (UTMD) United States $0.392B 28.40
Owens & Minor (OMI) United States $0.364B 13.47
Zynex (ZYXI) United States $0.346B 39.19
BioLife Solutions (BLFS) United States $0.325B 132.50
Bovie Medical (APYX) United States $0.286B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.272B 0.00
Female Health (VERU) United States $0.267B 0.00
Vapotherm (VAPO) United States $0.252B 0.00
United Health Products (UEEC) United States $0.233B 0.00
Viemed Healthcare (VMD) United States $0.216B 22.80
Repro-Med Systems (KRMD) United States $0.215B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.188B 0.00
Rockwell Medical (RMTI) United States $0.182B 0.00
Liberty Health Sciences (LHSIF) Canada $0.175B 0.00
InfuSystems Holdings (INFU) United States $0.171B 861.00
Cytosorbents (CTSO) United States $0.151B 0.00
Chimerix (CMRX) United States $0.127B 0.00
MTech Acquisition (KERN) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
United-Guardian (UG) United States $0.090B 22.83
MRI Interventions (MRIC) United States $0.087B 0.00
Surface Oncology (SURF) United States $0.087B 0.00
Nephros (NEPH) United States $0.079B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
FSD PHARMA INC (HUGE) $0.046B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Myomo (MYO) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00